KIMBERLY BUXTON: Open Payments
NPI 1790223709 · POPLAR BLUFF, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$163 in 8 payments from 5 companies in 2025. Trend: 2023 $7 · 2024 $266 · 2025 $163
Food & beverage: $163
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $79 |
| Sequel Med Tech, LLC | 1 | $29 |
| Abbott Laboratories | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: Ozempic, TWIIST, FREESTYLE LIBRE 3, GEMTESA, MOUNJARO.
Industry payments across MO — which companies pay providers there.
